High Bleeding Risk
Also known as: Significant Bleeding Risk / Increased risk of bleeding events / High Risk Bleeding / High Risk of Blood Loss / High risk of bleeding / High Bleeding Risk Patients / Increased risk of bleeding / At risk for bleeding / At high risk for bleeding (finding)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06210 | Eltrombopag | A thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies. |
| DB00016 | Erythropoietin | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB13152 | Coagulation Factor IX Human | 3 | Completed | 1 |
| DB13150 | Coagulation factor VII human | 3 | Completed | 1 |
| DB13148 | Coagulation factor X human | 3 | Completed | 1 |
| DB11330 | Factor IX Complex (Human) | 3 | Completed | 1 |
| DB11312 | Protein C | 3 | Completed | 1 |
| DB13149 | Protein S human | 3 | Completed | 1 |
| DB11311 | Prothrombin | 3 | Completed | 1 |
| DB15763 | Iron polymaltose | 4 | Terminated | 1 |
| DB00945 | Acetylsalicylic acid | Not Available | Completed | 1 |